APA (7th ed.) Citation

Schnell, A., Hober, H., Kaiser, N., Ruppel, R., Geppert, A., Tremel, C., . . . Hoerning, A. (2023). Elexacaftor – Tezacaftor – Ivacaftor treatment improves systemic infection parameters and Pseudomonas aeruginosa colonization rate in patients with cystic fibrosis a monocentric observational study. Friedrich-Alexander-Universität Erlangen-Nürnberg.

Chicago Style (17th ed.) Citation

Schnell, Alexander, et al. Elexacaftor – Tezacaftor – Ivacaftor Treatment Improves Systemic Infection Parameters and Pseudomonas Aeruginosa Colonization Rate in Patients with Cystic Fibrosis a Monocentric Observational Study. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.

MLA (9th ed.) Citation

Schnell, Alexander, et al. Elexacaftor – Tezacaftor – Ivacaftor Treatment Improves Systemic Infection Parameters and Pseudomonas Aeruginosa Colonization Rate in Patients with Cystic Fibrosis a Monocentric Observational Study. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2023.